Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Sea Anemone Genome Reveals Ancestral Eumetazoan Gene Repertoire and Genomic Organization
2007 StandoutScience
Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients
2007 StandoutNobel
Geography of HFE C282Y and H63D Mutations
2000
Receptor-mediated low density lipoprotein catabolism in man.
1979
Cardiovascular and Metabolic Alterations in Mice Lacking Both β1- and β2-Adrenergic Receptors
1999 StandoutNobel
Thiazolidinediones
2004 Standout
Biochemistry and pathophysiology of intravascular and intracellular lipolysis
2013
Dynamics of fat cell turnover in humans
2008 StandoutNature
Targeted Disruption of the β2 Adrenergic Receptor Gene
1999 StandoutNobel
Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B
1990 Standout
Transcription Activation by the Orphan Nuclear Receptor, Chicken Ovalbumin Upstream Promoter-Transcription Factor I (COUP-TFI)
2000
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
2001 StandoutNature
The orphan COUP-TF nuclear receptors are markers for neurogenesis from cnidarians to vertebrates
2004
The metabolic syndrome
2010 Standout
Relation of Serum Lipoprotein(a) Concentration and Apolipoprotein(a) Phenotype to Coronary Heart Disease in Patients with Familial Hypercholesterolemia
1990
The Degradation of Apolipoprotein B100 Is Mediated by the Ubiquitin-proteasome Pathway and Involves Heat Shock Protein 70
1997 StandoutNobel
Hepatocellular carcinoma
2012 Standout
Combination of interferon induction therapy and ribavirin in chronic hepatitis C
2001
Coronary heart disease: seven dietary factors
1991 Standout
Metabolic origins and clinical significance of LDL heterogeneity
2002
Lipoprotein (a). Heterogeneity and biological relevance.
1990
The mitochondrial uncoupling-protein homologues
2005
The metabolic syndrome
2005 Standout
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
2010 Standout
Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression
2009
Free Fatty Acid-induced β-Cell Defects Are Dependent on Uncoupling Protein 2 Expression
2004
In vivo genome editing using Staphylococcus aureus Cas9
2015 StandoutNature
The Importance of Race and Ethnic Background in Biomedical Research and Clinical Practice
2003 Standout
Advanced sorting of single-walled carbon nanotubes by nonlinear density-gradient ultracentrifugation
2010
Evolution of the mammalian transcription factor binding repertoire via transposable elements
2008
Prescribing Personalized Nutrition for Cardiovascular Health: Are We Ready?
2014 Standout
Lipoprotein (a) and plasminogen are immunochemically related
1988
What We Talk About When We Talk About Fat
2014 Standout
The Human Obesity Gene Map: The 2003 Update
2004
Lipoprotein metabolism and its relationship to atherosclerosis
1994
Inference of human population history from individual whole-genome sequences
2011 StandoutNature
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Atherosclerosis
2000 StandoutNature
Disorders of Iron Metabolism
1999 Standout
The Prevalence and Etiology of Elevated Aminotransferase Levels in The United States
2003
Hepatocellular Carcinoma
2011 Standout
A 3D Map of the Human Genome at Kilobase Resolution Reveals Principles of Chromatin Looping
2014 Standout
A Prospective Study of Moderate Alcohol Consumption and the Risk of Coronary Disease and Stroke in Women
1988 Standout
Respiratory Uncoupling Lowers Blood Pressure Through a Leptin-Dependent Mechanism in Genetically Obese Mice
2002
Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin.
1989
Lipoprotein(a). A unique risk factor for atherothrombotic disease.
1990
Oxidants, antioxidants, and the degenerative diseases of aging.
1993 Standout
Peroxisome Proliferator-Activated Receptor-γ Coactivator-1 Gene Locus
2002
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Immunologic cross-reactivity of the low density lipoprotein receptor from bovine adrenal cortex, human fibroblasts, canine liver and adrenal gland, and rat liver.
1981 StandoutNobel
Genetic Models of Human Vascular Disease
1995 StandoutNobel
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
Effects of age, sex, and clinical conditions on adipose tissue cellularity in man
1974
Uncoupling Protein 2 Promoter Polymorphism −866G/A Affects Its Expression in β-Cells and Modulates Clinical Profiles of Japanese Type 2 Diabetic Patients
2004
Orphan Nuclear Receptors: From Gene to Function*
1999
Nuclear Receptors and Lipid Physiology: Opening the X-Files
2001 StandoutScience
Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals.
1995 StandoutNobel
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
2002 Standout
Lipoprotein Lipase Mutations, Plasma Lipids and Lipoproteins, and Risk of Ischemic Heart Disease
1999
Cholestyramine Promotes Receptor-Mediated Low-Density-Lipoprotein Catabolism
1980
A Common Polymorphism in the Promoter of UCP2 Contributes to the Variation in Insulin Secretion in Glucose-Tolerant Subjects
2003
Association of HFE protein with transferrin receptor in crypt enterocytes of human duodenum
1999
Effects of cholestyramine on receptor-mediated plasma clearance and tissue uptake of human low density lipoproteins in the rabbit.
1980
Regulation of Plasma Cholesterol by Lipoprotein Receptors
1981 StandoutScienceNobel
A Functional Polymorphism in the Promoter of UCP2 Enhances Obesity Risk but Reduces Type 2 Diabetes Risk in Obese Middle-Aged Humans
2002
A Receptor-Mediated Pathway for Cholesterol Homeostasis
1986 StandoutScienceNobel
Malondialdehyde modification of lipoprotein(a) produces avid uptake by human monocyte-macrophages.
1992
Determination of heparin-induced lipoprotein lipase activity in human plasma
1964
Delayed clearance of very low density and intermediate density lipoproteins with enhanced conversion to low density lipoprotein in WHHL rabbits.
1982 StandoutNobel
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
1967 Standout
The Mysteries Of Lipoprotein(a)
1989 Science
Supramolecular Helical Systems: Helical Assemblies of Small Molecules, Foldamers, and Polymers with Chiral Amplification and Their Functions
2016 Standout
Transcriptional inhibition of the interleukin-8 gene by interferon is mediated by the NF-kappa B site.
1994
High density and low density lipoprotein subfractions in survivors of myocardial infarction and in control subjects
1982
Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role ofPGC1andNRF1
2003 Standout
Mitochondrial Dysfunction and Type 2 Diabetes
2005 StandoutScience
Biosynthesis of Apolipoprotein B48-containing Lipoproteins
1996 StandoutNobel
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
2015 Standout
Cloning and mutagenesis of the rabbit ApoB mRNA editing protein. A zinc motif is essential for catalytic activity, and noncatalytic auxiliary factor(s) of the editing complex are widely distributed.
1994 StandoutNobel
The gut microbiota as an environmental factor that regulates fat storage
2004 Standout
The Measurement of Apolipoprotein A-I and A-II Levels in Men and Women by Immunoassay
1977
Sudden death associated with very low calorie weight reduction regimens
1981
Visualizing Individual Carbon Nanotubes with Optical Microscopy
2014 StandoutNobel
Effect of beta-adrenergic blockade on biochemical and metabolic response to exercise
1985
Recent progress in understanding apolipoprotein B.
1990
Reconstitution of lipoprotein(a) by infusion of human low density lipoprotein into transgenic mice expressing human apolipoprotein(a).
1992
Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
2017 StandoutNobel
Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows.
1981 StandoutNobel
Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog.
1981 StandoutNobel
Effects of Dietary Polyunsaturated and Saturated Fat on the Properties of High Density Lipoproteins and the Metabolism of Apolipoprotein A-I
1978
The complete cDNA and amino acid sequence of human apolipoprotein B-100.
1986
Liver Transplantation to Provide Low-Density-Lipoprotein Receptors and Lower Plasma Cholesterol in a Child with Homozygous Familial Hypercholesterolemia
1984 StandoutNobel
Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.
1986
Works of F. Sandhofer being referenced
The natural course of hepatitis C virus infection 18 years after an epidemic outbreak of non-A, non-B hepatitis in a plasmapheresis centre
1999
Severe cardiovascular complication associated with prolonged starvation.
1973
Molecular basis of lipoprotein lipase deficiency in two Austrian families with type I hyperlipoproteinemia
1991
Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities.
1993
Predominance of the HLA-H Cys282Tyr mutation in Austrian patients with genetic haemochromatosis
1997
A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans
2001
Separation of the main lipoprotein density classes from human plasma by rate-zonal ultracentrifugation
1974
Einfluß einer akuten β1 und β1/β2-Rezeptorenblockade auf den Kohlenhydrat- und Fettstoffwechsel unter Belastungsbedingungen
2008
Untersuchungen �ber die Lipoproteinlipase
1961
Lipoprotein (a) is not a metabolic product of other lipoproteins containing apolipoprotein B
1979
Studies on the role of specific cell surface receptors in the removal of lipoprotein (a) in man.
1983
The Mechanism by Which the Human Apolipoprotein B Gene Reducer Operates Involves Blocking of Transcriptional Activation by Hepatocyte Nuclear Factor 3
1993
Apolipoprotein B gene mutations in Austrian subjects with heart disease and their kindred.
1991
Turnover of Lipoprotein (a) in Man
1980
Untersuchungen an isolierten menschlichen Fettzellen verschiedener Fettgewebsregionen
1970
Functional Domains of the Human Orphan Receptor ARP-1/ COUP-TFII Involved in Active Repression and Transrepression
1997
The interaction of human apoB-containing lipoproteins with mouse peritoneal macrophages: a comparison of Lp(a) with LDL.
1984
Hypervariability in a minisatellite 3' of the apolipoprotein B gene in patients with coronary heart disease compared with normal controls.
1990